Patient safety in primary health care and polypharmacy: cross-sectional survey among patients with chronic diseases
Objective: to characterize and determine the polypharmacy prevalence in patients with chronic diseases and to identify the factors associated, in order to improvement of pharmaceutical care focused on patient safety. Methods: cross-sectional study included 558 patients, covered by primary health care, using a household and structured questionnaire. We analyzed the data on polypharmacy and its clinical and socioeconomic factors. Poisson regression analysis with robust variance was applied, with results expressed in prevalence ratio. Results: the results showed that polypharmacy (consumption of four or more drugs) was of 37.6%. The prevalence ratio analyses identified independent variables associated with polypharmacy: age (3.05), economic strata (0.33), way of medication acquisition through a combination of out-of-pocket and Brazilian public health system (1.44), diabetes and hypertension (2.11), comorbidities (coronary artery disease 2.26) and hospital admission (1.73). In the analyses, inappropriate medication use of the 278 patients (≥ 65 years) was associated with polypharmacy (prevalence ratio 4.04). Conclusion: polypharmacy study becomes an opportunity to guide the strategies for the patient safety to promote the medication without harm in chronic diseases.
Main Authors: | , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Escola de Enfermagem de Ribeirão Preto / Universidade de São Paulo
2019
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-11692019000100398 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S0104-11692019000100398 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S0104-116920190001003982019-11-29Patient safety in primary health care and polypharmacy: cross-sectional survey among patients with chronic diseasesAraújo,Lorena UlhôaSantos,Delba FonsecaBodevan,Emerson CottaCruz,Hellen Lilliane daSouza,Jacqueline deSilva-Barcellos,Neila Márcia Pharmacoepidemiology Polypharmacy Potentially Inappropriate Medication List Primary Health Care Patient Safety Chronic Disease Objective: to characterize and determine the polypharmacy prevalence in patients with chronic diseases and to identify the factors associated, in order to improvement of pharmaceutical care focused on patient safety. Methods: cross-sectional study included 558 patients, covered by primary health care, using a household and structured questionnaire. We analyzed the data on polypharmacy and its clinical and socioeconomic factors. Poisson regression analysis with robust variance was applied, with results expressed in prevalence ratio. Results: the results showed that polypharmacy (consumption of four or more drugs) was of 37.6%. The prevalence ratio analyses identified independent variables associated with polypharmacy: age (3.05), economic strata (0.33), way of medication acquisition through a combination of out-of-pocket and Brazilian public health system (1.44), diabetes and hypertension (2.11), comorbidities (coronary artery disease 2.26) and hospital admission (1.73). In the analyses, inappropriate medication use of the 278 patients (≥ 65 years) was associated with polypharmacy (prevalence ratio 4.04). Conclusion: polypharmacy study becomes an opportunity to guide the strategies for the patient safety to promote the medication without harm in chronic diseases.info:eu-repo/semantics/openAccessEscola de Enfermagem de Ribeirão Preto / Universidade de São PauloRevista Latino-Americana de Enfermagem v.27 20192019-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-11692019000100398en10.1590/1518-8345.3123.3217 |
institution |
SCIELO |
collection |
OJS |
country |
Brasil |
countrycode |
BR |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-br |
tag |
revista |
region |
America del Sur |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Araújo,Lorena Ulhôa Santos,Delba Fonseca Bodevan,Emerson Cotta Cruz,Hellen Lilliane da Souza,Jacqueline de Silva-Barcellos,Neila Márcia |
spellingShingle |
Araújo,Lorena Ulhôa Santos,Delba Fonseca Bodevan,Emerson Cotta Cruz,Hellen Lilliane da Souza,Jacqueline de Silva-Barcellos,Neila Márcia Patient safety in primary health care and polypharmacy: cross-sectional survey among patients with chronic diseases |
author_facet |
Araújo,Lorena Ulhôa Santos,Delba Fonseca Bodevan,Emerson Cotta Cruz,Hellen Lilliane da Souza,Jacqueline de Silva-Barcellos,Neila Márcia |
author_sort |
Araújo,Lorena Ulhôa |
title |
Patient safety in primary health care and polypharmacy: cross-sectional survey among patients with chronic diseases |
title_short |
Patient safety in primary health care and polypharmacy: cross-sectional survey among patients with chronic diseases |
title_full |
Patient safety in primary health care and polypharmacy: cross-sectional survey among patients with chronic diseases |
title_fullStr |
Patient safety in primary health care and polypharmacy: cross-sectional survey among patients with chronic diseases |
title_full_unstemmed |
Patient safety in primary health care and polypharmacy: cross-sectional survey among patients with chronic diseases |
title_sort |
patient safety in primary health care and polypharmacy: cross-sectional survey among patients with chronic diseases |
description |
Objective: to characterize and determine the polypharmacy prevalence in patients with chronic diseases and to identify the factors associated, in order to improvement of pharmaceutical care focused on patient safety. Methods: cross-sectional study included 558 patients, covered by primary health care, using a household and structured questionnaire. We analyzed the data on polypharmacy and its clinical and socioeconomic factors. Poisson regression analysis with robust variance was applied, with results expressed in prevalence ratio. Results: the results showed that polypharmacy (consumption of four or more drugs) was of 37.6%. The prevalence ratio analyses identified independent variables associated with polypharmacy: age (3.05), economic strata (0.33), way of medication acquisition through a combination of out-of-pocket and Brazilian public health system (1.44), diabetes and hypertension (2.11), comorbidities (coronary artery disease 2.26) and hospital admission (1.73). In the analyses, inappropriate medication use of the 278 patients (≥ 65 years) was associated with polypharmacy (prevalence ratio 4.04). Conclusion: polypharmacy study becomes an opportunity to guide the strategies for the patient safety to promote the medication without harm in chronic diseases. |
publisher |
Escola de Enfermagem de Ribeirão Preto / Universidade de São Paulo |
publishDate |
2019 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0104-11692019000100398 |
work_keys_str_mv |
AT araujolorenaulhoa patientsafetyinprimaryhealthcareandpolypharmacycrosssectionalsurveyamongpatientswithchronicdiseases AT santosdelbafonseca patientsafetyinprimaryhealthcareandpolypharmacycrosssectionalsurveyamongpatientswithchronicdiseases AT bodevanemersoncotta patientsafetyinprimaryhealthcareandpolypharmacycrosssectionalsurveyamongpatientswithchronicdiseases AT cruzhellenlillianeda patientsafetyinprimaryhealthcareandpolypharmacycrosssectionalsurveyamongpatientswithchronicdiseases AT souzajacquelinede patientsafetyinprimaryhealthcareandpolypharmacycrosssectionalsurveyamongpatientswithchronicdiseases AT silvabarcellosneilamarcia patientsafetyinprimaryhealthcareandpolypharmacycrosssectionalsurveyamongpatientswithchronicdiseases |
_version_ |
1756408565683191808 |